101 – 110 of 132
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders
(
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson’s disease and atypical parkinsonian disorders
(
- Contribution to journal › Article
-
Mark
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
(
- Contribution to journal › Article
- 2017
-
Mark
Concordance between different amyloid immunoassays and Visual amyloid positron emission tomographic assessment
(
- Contribution to journal › Article
-
Mark
Exendin-4 treatment improves LPS-induced depressive-like behavior without affecting pro-inflammatory cytokines
(
- Contribution to journal › Article
-
Mark
CSF/serum albumin ratio in dementias : a cross-sectional study on 1861 patients
(
- Contribution to journal › Article
-
Mark
Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1-42)/Aβ(1-40)
(
- Contribution to journal › Article
-
Mark
Blood-based NfL : A biomarker for differential diagnosis of parkinsonian disorder
(
- Contribution to journal › Article
-
Mark
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
(
- Contribution to journal › Article
- 2016
-
Mark
Cerebrospinal fluid neurogranin and YKL-40 as biomarkers of Alzheimer's disease.
(
- Contribution to journal › Article